Effects of Rosiglitazone on Serum Levels of Lipids and Inflammatory Factors in Atherosclerotic Rats
MAO Wei,CHEN Jun-zhu
DOI: https://doi.org/10.3969/j.issn.1007-7693.2007.03.007
2007-01-01
Abstract:OBJECTIVE To explore the effects of rosiglitazone on serum levels of lipids and inflammatory factors in atherosclerotic rats.METHODS 55 male Wistar rats were randomly divided into 3 groups,the normal group(N,n=20) with ordinary diet for 12 weeks,the model group(M,n=20) and the treatment group(RSG,n=15) with intra-abdominal injection of a single dose of vitamin D3(400,000 IU·kg-1) and atherogenic diet for 6 weeks,then be administered with normal saline(10 mg·kg-1·d-1) and rosiglitazone(3 mg·kg-1·d-1),respectively for 6 weeks.Before and after treatment the serum levels of total cholesterol(TC),triglyceride(TG),low density lipoprotein-cholesterol(LDL-C),high density lipoprotein-cholesterol(HDL-C) and pathomorphology in heart tissue were detected.The levels of serum C-reactive protein(CRP),monocyte chemoattractant protein-1(MCP-1) and intercellular adhesion molecule-1(ICAM-1) were determined by ELISA. RESULTS 6 weeks later the model group rats showed high serum levels of TC,TG,LDL-C,CRP,MCP-1,ICAM-1 and low serum level of HDL-C than that of the normal group(P0.05).Coronary atherosclerotic plaques had been observed.After treatment for 6 weeks,compared with the model group rats,rosiglitazone could significantly reduce the levels of serum TC,TG,LDL-C,CRP and MCP-1(P0.05 or P0.01),which were still higher than that of the normal group(P0.05).However,the changes of the serum HDL-C and ICAM-1 levels has no difference(P0.05).The pathomorphology degree of coronary atherosclerosis has decreased significantly.CONCLUSION Rosiglitazone can reduce the serum levels of TC,TG,LDL-C and inhibit the production of CRP and MCP-1,which may account for the anti-arterioisclerosis effects.